Insider Trading Alert - RHI, SEIC And MSON Traded By Insiders - TheStreet

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 24, 2015, 75 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $542.19 to $168,250,000.00.

Highlighted Stocks Traded by Insiders:

Robert Half International (RHI) - FREE Research Report

Messmer Harold M Jr, who is Chairman & CEO at Robert Half International, sold 100,000 shares at $61.21 on Feb. 24, 2015. Following this transaction, the Chairman & CEO owned 1.1 million shares meaning that the stake was reduced by 8.23% with the 100,000-share transaction.

The shares most recently traded at $62.76, up $1.55, or 2.47% since the insider transaction. Historical insider transactions for Robert Half International go as follows:

  • 4-Week # shares bought: 19,768
  • 4-Week # shares sold: 300,000
  • 12-Week # shares bought: 19,768
  • 12-Week # shares sold: 300,000
  • 24-Week # shares bought: 19,768
  • 24-Week # shares sold: 421,899

The average volume for Robert Half International has been 841,400 shares per day over the past 30 days. Robert Half International has a market cap of $8.4 billion and is part of the services sector and diversified services industry. Shares are up 7.91% year-to-date as of the close of trading on Tuesday.

Robert Half International Inc. provides staffing and risk consulting services in North America, South America, Europe, Asia, and Australia. The stock currently has a dividend yield of 1.28%. The company has a P/E ratio of 27.6. Currently, there are 8 analysts who rate Robert Half International a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RHI - FREE

TheStreet Quant Ratings

rates Robert Half International as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Robert Half International Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

SEI Investments Company (SEIC) - FREE Research Report

Doran William, who is Director at SEI Investments Company, sold 2,000 shares at $43.36 on Feb. 24, 2015. Following this transaction, the Director owned 770,534 shares meaning that the stake was reduced by 0.26% with the 2,000-share transaction.

The shares most recently traded at $43.43, up $0.07, or 0.16% since the insider transaction. Historical insider transactions for SEI Investments Company go as follows:

  • 4-Week # shares sold: 8,000
  • 12-Week # shares sold: 83,117
  • 24-Week # shares sold: 325,617

The average volume for SEI Investments Company has been 534,300 shares per day over the past 30 days. SEI Investments Company has a market cap of $7.2 billion and is part of the financial sector and financial services industry. Shares are up 7.49% year-to-date as of the close of trading on Tuesday.

SEI Investments Co. is a publicly owned investment manager. The firm provides wealth management and investment advisory services to its clients through its subsidiaries. The stock currently has a dividend yield of 1.12%. The company has a P/E ratio of 23.2. Currently, there are 3 analysts who rate SEI Investments Company a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SEIC - FREE

TheStreet Quant Ratings

rates SEI Investments Company as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

SEI Investments Company Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Misonix (MSON) - FREE Research Report

Manna Ronald, who is VP, Quality & Reg. Aff. at Misonix, sold 18,000 shares at $11.28 on Feb. 24, 2015. Following this transaction, the VP, Quality & Reg. Aff. owned 36,875 shares meaning that the stake was reduced by 32.8% with the 18,000-share transaction.

The shares most recently traded at $11.08, down $0.20, or 1.83% since the insider transaction. Historical insider transactions for Misonix go as follows:

  • 4-Week # shares bought: 45,000
  • 4-Week # shares sold: 36,475
  • 12-Week # shares bought: 45,000
  • 12-Week # shares sold: 36,475
  • 24-Week # shares bought: 47,500
  • 24-Week # shares sold: 62,894

The average volume for Misonix has been 24,000 shares per day over the past 30 days. Misonix has a market cap of $84.9 million and is part of the health care sector and health services industry. Shares are down 10.99% year-to-date as of the close of trading on Tuesday.

Misonix, Inc., a surgical device company, designs, develops, manufactures, and markets minimally invasive ultrasonic surgical device products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications. The company has a P/E ratio of 30.1. Currently, there are no analysts who rate Misonix a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSON - FREE

TheStreet Quant Ratings

rates Misonix as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

Misonix Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null